NASDAQ

Biostem Technologies Inc

BSEM医療関連
3.80
前日比
+0.19(+5.26%)
  • 15分ディレイ株価

Biostem Technologies Incの企業情報(従業員数・代表者名など)

最終更新日:2026年8月12日

特色

BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The Company's products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AMERICAN AMNION. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. It also owns BioTissue's surgical and wound care business, including the Neox and Clarix product lines.

企業情報

英文社名

Biostem Technologies Inc

本社所在地

2836 Center Port Cir POMPANO BEACH, FL 33064 USA

電話番号

954 380-8342

設立年月

2009年2月

代表者名

Jason Matuszewski

業種名

医療関連(Health Care)

市場名

---

従業員数

---

ウェブサイト

https://www.biostemtechnologies.com/